|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.572 USD | -3.75% |
|
-5.28% | -23.28% |
| 05-15 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Onconova Therapeutics, Inc. strengthened its team with the appointment of Adar Makovski Silverstein, Ph.D., as Director, Corporate Development.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.28% | 12.53M | |
| +55.70% | 55.7B | |
| +41.08% | 39.91B | |
| -5.39% | 39.57B | |
| -5.56% | 28.16B | |
| +16.46% | 26.3B | |
| -20.56% | 18.94B | |
| +33.03% | 12.17B | |
| +25.85% | 12.12B | |
| +2.72% | 12.12B |
TRAWS PHARMA, INC. 
